Journal of Alzheimers Disease & Parkinsonism
Open Access

The New FDA Approved Drug for Alzheimer’s disease, Aducanumab, and what Patients should know?

Troy T. Rohn^*

Department of Biological Sciences, Boise State University, Boise, U.S.A

Received Date: Aug 04, 2021 / Accepted Date: Aug 18, 2021 / Published Date: Aug 25, 2021

Citation: Rohn TT (2021) The New FDA Approved Drug for Alzheimer’s disease, Aducanumab, and what Patients should know? J Alzheimers Dis Parkinsonism S5: 019.DOI: 10.4172/2161-0460.s5.1000019

Copyright: © 2021 Rohn TT. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF | Peer-reviewed Full Article